Clinical Trials · NCT06867835
Single Dose of Vyleesi in Lactating Female Subjects to Measure the Concentration of Bremelanotide in Breast Milk
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Cosette Pharmaceuticals, Inc.
- Enrollment
- 10
- Start date
- Jul 2025
- Locations
- 1 site, United States
- Primary endpoint
- Levels of Bremelanotide (BMT) in Breast Milk Over 24h After Administration of Vyleesi